Return of inactivated whole‐virus vaccine for superior efficacy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Immunology and Cell Biology

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/icb.2011.70PMID 21844883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolving Strategies for the Prevention of Influenza Infection

  2012cited by this paper
• Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.

  2011cited by this paper
• Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets

  2011cited by this paper
• Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial.

  2011cited by this paper
• Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010.

  2010cited by this paper
• Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses

  2010cited by this paper
• A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture

  2010cited by this paper
• Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

  2010cited by this paper
• Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.

  2010cited by this paper
• Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations.

  2010cited by this paper
• Altering hemagglutinin binding to B cells modulates original antigenic sin responses to influenza viruses (92.23)

  2010cited by this paper
• Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by γ-Irradiated Influenza A Viruses

  2010cited by this paper
• Original Antigenic Sin Responses to Influenza Viruses1

  2009cited by this paper
• Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections

  2009cited by this paper
• A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

  2009cited by this paper
• Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults.

  2009cited by this paper
• Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults.

  2009cited by this paper
• Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

  2009cited by this paper
• Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus

  2009cited by this paper
• Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program.

  2009cited by this paper
• Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

  2009cited by this paper
• Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs

  2008cited by this paper
• Mutational Analysis of cis-Acting RNA Signals in Segment 7 of Influenza A Virus

  2008cited by this paper
• Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus

  2008cited by this paper
• Heterosubtypic immunity to influenza A virus: where do we stand?

  2008cited by this paper
• Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

  2008cited by this paper
• A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

  2008cited by this paper
• Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

  2008cited by this paper
• Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

  2008cited by this paper
• Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.

  2008cited by this paper
• Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

  2007cited by this paper
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

  2007cited by this paper
• Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

  2007cited by this paper
• Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization

  2007cited by this paper
• Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review

  2007cited by this paper
• Toxicity of Influenza A Virus Matrix Protein 2 for Mammalian Cells is Associated with its Intrinsic Proton-Channeling Activity

  2007cited by this paper
• Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.

  2007cited by this paper
• Clinical evaluation of adjuvants

  2006cited by this paper
• Development of vaccines against influenza H5.

  2006cited by this paper
• T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1

  2006cited by this paper
• Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

  2006cited by this paper
• Distinct Contributions of Vaccine-Induced Immunoglobulin G1 (IgG1) and IgG2a Antibodies to Protective Immunity against Influenza

  2006cited by this paper
• Advances in the development of inactivated virus vaccines.

  2006cited by this paper
• Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

  2006cited by this paper
• Consumer Knowledge and Perceptions of Food Irradiation: Ground Beef Study

  2006cited by this paper
• Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

  2006cited by this paper
• Vaccination with irradiated Listeria induces protective T cell immunity.

  2006cited by this paper
• Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay.

  2006cited by this paper
• Avian influenza A (H5N1) infection in humans.

  2005cited by this paper
• Universal influenza A vaccine: optimization of M2-based constructs.

  2005cited by this paper
• The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.

  2005cited by this paper
• Virus inactivation studies using ion beams, electron and gamma irradiation

  2005cited by this paper
• Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants.

  2005cited by this paper
• Induction of Antigen-Specific Th1-Type Immune Responses by Gamma-Irradiated Recombinant Brucella abortus RB51

  2005cited by this paper
• Two Doses of Parenterally Administered Split Influenza Virus Vaccine Elicited High Serum IgG Concentrations which Effectively Limited Viral Shedding upon Challenge in Mice

  2005cited by this paper
• NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells

  2005cited by this paper
• Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice

  2005cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Induction of Antigen-Specific Th 1-Type Immune Responses by Gamma-Irradiated Recombinant Brucella abortus RB 51

  2005cited by this paper
• Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

  2004cited by this paper
• Functional Compensation of a Detrimental Amino Acid Substitution in a Cytotoxic-T-Lymphocyte Epitope of Influenza A Viruses by Comutations

  2004cited by this paper
• A Mutation in the HLA-B*2705-Restricted NP383-391 Epitope Affects the Human Influenza A Virus-Specific Cytotoxic T-Lymphocyte Response In Vitro

  2004cited by this paper
• A "universal" human influenza A vaccine.

  2004cited by this paper
• Duration of antiviral immunity after smallpox vaccination

  2003cited by this paper
• The annual production cycle for influenza vaccine.

  2003cited by this paper
• Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.

  2003cited by this paper
• Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

  2003cited by this paper
• MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

  2003cited by this paper
• Mortality associated with influenza and respiratory syncytial virus in the United States.

  2003cited by this paper
• Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins.

  2003cited by this paper
• 200 Gy sterilised Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice.

  2002cited by this paper
• Ageing and infection.

  2002cited by this paper
• DIAGNOSIS OF LEGIONELLA INFECTION

  2002cited by this paper
• Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

  2002cited by this paper
• Vaccines and vaccination.

  2001cited by this paper
• Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

  2001cited by this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cited by this paper
• Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

  2001cited by this paper
• Consumer acceptance of irradiated meat and poultry in the United States.

  2001cited by this paper
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

  2001cited by this paper
• Comparison of gamma and neutron radiation inactivation of influenza A virus.

  2001cited by this paper
• Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly.

  2000cited by this paper
• Immunity to influenza in the elderly.

  2000cited by this paper
• Memory B-cell persistence is independent of persisting immunizing antigen

  2000cited by this paper
• Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic

  1999cited by this paper
• Surveillance and impact of influenza in Europe. Groupe Régional d'Observation de la Grippe and European Influenza Surveillance Scheme.

  1999cited by this paper
• The postvaccination antibody response to influenza virus proteins

  1999cited by this paper
• Generating MHC class I ligands from viral gene products

  1999cited by this paper
• A universal influenza A vaccine based on the extracellular domain of the M2 protein

  1999cited by this paper
• Surveillance and impact of influenza in the United States.

  1999cited by this paper
• Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.

  1999cited by this paper
• Modified M2 proteins produce heterotypic immunity against influenza A virus.

  1999cited by this paper
• Surveillance and impact of influenza in Europe

  1999cited by this paper
• Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins

  1998cited by this paper
• Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

  1998cited by this paper
• Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines

  1998cited by this paper
• [Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children--a 12-year follow-up].

  1998cited by this paper
• Erythrocytes enhance the immunogenicity of oral vaccination with gamma irradiated influenza virus: increasing the dose of irradiation results in a significant diminution of lung IgA response.

  1997cited by this paper
• [Vaccines and vaccination].

  1997cited by this paper
• A comparison of the immunogenicity of the native and denatured forms of a protein

  1996cited by this paper

• Novel recombinant H5-based vaccine provides effective protection against H5N1 influenza virus in cats

  2026cites this paper
• Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy

  2025cites this paper
• Vaccine Quality Challenges in Secretly Traded H5 and H9 Avian Influenza Vaccines in Nigeria

  2024cites this paper
• Physical and Chemical Inactivators Evaluation for the Puumala Virus Vaccine Technology Development

  2024cites this paper
• Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses

  2024cites this paper
• Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

  2023cites this paper
• Immune Control of Avian Influenza Virus Infection and Its Vaccine Development

  2023cites this paper
• Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?

  2022cites this paper
• Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes

  2022cites this paper
• Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world

  2022cites this paper
• Viral inactivation by light

  2022cites this paper
• Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model

  2022cites this paper
• Advances in Irradiated Livestock Vaccine Research and Production Addressing the Unmet Needs for Farmers and Veterinary Services in FAO/IAEA Member States

  2022cites this paper
• Low-Energy Electron Irradiation of Tick-Borne Encephalitis Virus Provides a Protective Inactivated Vaccine

  2022cites this paper
• A global survey in the developmental landscape of possible vaccination strategies for COVID-19

  2022cites this paper
• COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development

  2021cites this paper
• Enhanced Immunogenicity of a Whole-Inactivated Influenza A Virus Vaccine Using Optimised Irradiation Conditions

  2021cites this paper
• The Recent Developmental Platforms and Potential Targets of SARS CoV-2 Vaccines: A Comprehensive Review

  2021cites this paper
• Radiation-Inactivated S. gallinarum Vaccine Provides a High Protective Immune Response by Activating Both Humoral and Cellular Immunity

  2021cites this paper
• A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients

  2021cites this paper
• Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses

  2021influential citation
• A novel gamma radiation-inactivated sabin-based polio vaccine

  2020cites this paper
• A review on Promising vaccine development progress for COVID-19 disease

  2020cites this paper
• Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine

  2020cites this paper
• Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities

  2020cites this paper
• Virus Irradiation and COVID-19 Disease

  2020cites this paper
• SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity

  2020cites this paper
• A review on Promising vaccine development progress for COVID-19 disease

  2020cites this paper
• Inactivation methods for whole influenza vaccine production

  2019influential citation
• Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

  2019cites this paper
• Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus

  2019cites this paper
• Seasonal influenza vaccine in immunocompromised persons

  2018cites this paper
• Towards improved and broadly protective influenza vaccines: Focus on delivery systems, routes of administration and animal models

  2018cites this paper
• Gamma-irradiation-killed Streptococcus pneumoniae potently induces the expression of IL-6 and IL-8 in human bronchial epithelial cells.

  2018cites this paper
• Opinion: Making Inactivated and Subunit-Based Vaccines Work

  2018cites this paper
• Chapter 2 Inactivated Viral Vaccines

  2017influential citation
• Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development.

  2017cites this paper
• Dose sparing and the lack of a dose–response relationship with an influenza vaccine in adult and elderly patients – a randomized, double‐blind clinical trial

  2017cites this paper
• Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge

  2016cites this paper
• A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice

  2016cites this paper
• Pathogens Inactivated by Low-Energy-Electron Irradiation Maintain Antigenic Properties and Induce Protective Immune Responses

  2016cites this paper
• Different Approaches to Counteracting Hepatitis C Virus and Chikungunya Virus Infections

  2016cites this paper
• Development of novel inactivated poliovirus vaccines: Breaking away from convention

  2015influential citation
• Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses

  2015cites this paper
• Prospects for Broadly Protective Influenza Vaccines.

  2015cites this paper
• Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens

  2015cites this paper
• Prospects for broadly protective influenza vaccines.

  2015cites this paper
• A New Adjuvant Combined with Inactivated Influenza Enhances Specific CD8 T Cell Response in Mice and Decreases Symptoms in Swine Upon Challenge

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Aliphatic Polyesters: Particulate Vaccine Delivery

  2015cites this paper
• Laser vaccine adjuvants

  2014cites this paper
• Membrane-bound IL-12 and IL-23 serve as potent mucosal adjuvants when co-presented on whole inactivated influenza vaccines

  2014cites this paper
• Inactivated Viral Vaccines

  2014influential citation
• Ebolavirus Nucleoprotein C-Termini Potently Attract Single Domain Antibodies Enabling Monoclonal Affinity Reagent Sandwich Assay (MARSA) Formulation

  2013cites this paper
• Near-Infrared Laser Adjuvant for Influenza Vaccine

  2013cites this paper
• Kinetics and phenotype of the draining lymph node and pulmonary B cell response to an influenza A virus-like particle vaccine

  2013cites this paper
• Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.

  2012cites this paper
• Viral Vaccines

  year unknowncites this paper